Data / Form D filings / MBQ PHARMA INC.
MBQ PHARMA INC.: Form D filings
MBQ PHARMA INC., a pharmaceuticals company in San Juan, PR, filed 5 Form D notices with the SEC in 2026. The latest, on August 14, 2026, reports $991,038 sold of an offering with no set size to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 998 AVE LUIS MUNOZ RIVERA, San Juan, PR, 00927
- Phone
- (216) 376-2125
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Puerto Rico
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2148840
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | New notice | Indefinite | $991,038 | 8 | May 15, 2026 | sec.gov | |
| Aug 14, 2026 | New notice | $500,000 | $500,000 | 2 | Aug 24, 2023 | sec.gov | |
| Aug 14, 2026 | New notice | $325,000 | $325,000 | 3 | Mar 30, 2022 | sec.gov | |
| Aug 14, 2026 | New notice | $882,000 | $882,000 | 3 | Feb 1, 2021 | sec.gov | |
| Aug 14, 2026 | New notice | Indefinite | $1,530,000 | 8 | Jun 30, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CARLOS A DOMINGUEZ | Executive Officer, Director | Chief Financial Officer |
| JOSE F RODRIGUEZ-ORENGO | Executive Officer, Director | Chief Executive Officer |
| SURANGANIE DHARMAWARDHANE | Executive Officer | Chief Scientific Officer |
| ARTURO GONZALEZ | Director | |
| NEIL SANKAR | Executive Officer | Chief Medical Officer |
Every Form D from the week of Aug 10, 2026 · All recent filings in Puerto Rico · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MBQ PHARMA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.